INTRODUCTION
There are two obvious ways by which the nervous system can communicate with the immune system. The first is via pituitary hormones and the second is via sympathetic, parasympathetic, and sensory peripheral nerves. This communication will be restricted to a discussion of the role that the sympathetic nervous system (SNS) plays in modulating immune responses and autoimmune diseases. The lymphoid organs, lymph nodes, spleen, thymus, and gut-associated lymphoid tissue receive an extensive sympathetic intraparenchymal innervation (Felten, Felten, & Bellinger, 1987; Kendall & Al-Shawaf, 1991; Bellinger, Lorton, Felten, & Felten, 1992; Madden & Felten, 1995; Bellinger, Felten, Lorton, & Felten, 1997) . SNS nerve endings contact T cells, monocytes, and to a lesser extent B cells. The function of SNS nerves within the lymphoid organs is regulated by products of immune system cells, while neurotransmitters and neuropeptides released by SNS nerves alter immune system cell responses.
Neurotransmitter receptors are present on immunocytes. Lymphocytes and macrophages possess β 2 adrenergic receptors. In man the highest number of receptors is present on B cells followed in declining order by NK cells, T suppressor cells, macrophages, T cytotoxic cells, and T helper cells. Binding of β adrenergic agonists to β 2 adrenergic receptors increases intracellular cAMP but the response correlates poorly with receptor number. T suppressor cells show the greatest increase in cAMP; B cells respond less well, suggesting that many B cell receptors are uncoupled. Elevated intracellular cAMP levels suppress cell proliferation and increase cell differentiation (Bourne, Lichtenstein, Melmon, Henney, Weinstein, & Shearer, 1974; Kahn, Sansoni, Silverman, Engleman, & Melmont, 1986; Maisel, Fowler, Rearden, Motulsky, & Michel, 1989; Karaszewski, Reder, Anlar, & Arnason, 1993) . β-Adrenergic receptor agonists have also been shown to upregulate B cell responses to LPS and to a T-cell-independent polyclonal activator, KpMPG, by a cAMP-independent pathway (Li, Kouassi, & Revillard, 1990) .
EFFECT OF SYMPATHETIC ABLATION ON IMMUNE RESPONSES AND ON AUTOIMMUNE DISEASES
We ablated the SNS in rodents using 6-hydroxydopamine (6-OHDA) and determined the consequences for immune responses. A permanent ablation of the SNS (sympathectomy) was achieved by injection of 6-OHDA into neonatal rats. 6-OHDA is a neurotoxin specific for nonadrenergic nerve endings. Destruction of the sympathetic nerve endings in newborn rodents precludes contact with the target tissue and causes death of sympathetic neurons. In adult rodents treatment with 6-OHDA results in a transient and reversible axotomy. Sympathetic nerve endings are temporarily
